| Symbol | COAG |
|---|---|
| Name | HEMAB THERAPEUTICS HOLDINGS, INC. |
| Sector | UNDEFINED |
| Region | UNDEFINED |
| Industry | Biological Products, (No Diagnostic Substances) |
| Address | 101 MAIN STREET, CAMBRIDGE, MA 02142 |
| Telephone | 45 2138 7627 |
| Fax | — |
| — | |
| Website | — |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0002114044 |
| Description | None |
Hemab Therapeutics Presents New Clinical Data from HMB-002 in Von Willebrand Disease and Introduces HMB-003 for Heavy Menstrual Bleeding at the ISTH 2026 Congress
Read moreHemab Therapeutics to Present Clinical and Preclinical Data from Multiple Blood Coagulation Programs at the ISTH 2026 Congress
Read moreRA CAPITAL MANAGEMENT, L.P. 🟢 acquired 67.7K shares of Hemab Therapeutics Holdings, Inc. (COAG) at $24.98 ($1.7M) Transaction Date: Jun 15, 2026 | Filing ID: 000665
Read more(30% Negative) HEMAB THERAPEUTICS HOLDINGS, INC. (COAG) Reports Q2 2026 Financial Results
Read moreRA CAPITAL MANAGEMENT, L.P. 🟢 acquired 6.4K shares of Hemab Therapeutics Holdings, Inc. (COAG) at $24.90 Transaction Date: May 12, 2026 | Filing ID: 000495
Read moreNew Form 3 - Hemab Therapeutics Holdings, Inc. <b>Filed:</b> 2026-05-14 <b>AccNo:</b> 0001193125-26-223979 <b>Size:</b> 26 KB
Read more(99% Neutral) HEMAB THERAPEUTICS HOLDINGS, INC. (COAG) Announces New Board Appointment
Read moreNew Form SCHEDULE 13G - Hemab Therapeutics Holdings, Inc. <b>Filed:</b> 2026-05-11 <b>AccNo:</b> 0001346824-26-000127 <b>Size:</b> 19 KB
Read moreNew Form SCHEDULE 13G - Hemab Therapeutics Holdings, Inc. <b>Filed:</b> 2026-05-08 <b>AccNo:</b> 0001172661-26-001639 <b>Size:</b> 13 KB
Read more